AlphaFold predicted structure
SERPING1 · P05155

Mean pLDDT
79.6/ 100
Confident
500 residues
Confidence breakdown
- Very high(≥ 90)66%
- Confident(70–90)7%
- Low(50–70)1%
- Very low(< 50)26%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
serpin family G member 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BOTH monoallelic and biallelic, autosomal or pseudoautosomalHereditary angioedema types I and II
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalhereditary angioedema with C1Inh deficiency
hereditary angioedema type 1
hereditary angioedema
angioedema
hereditary angioedema type 2
C1 inhibitor deficiency
hereditary disease
Bartholin gland disease
asthma
complement deficiency
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Plasma protease C1 inhibitor
Serine protease inhibitor, which acrs as a regulator of the classical complement pathway (PubMed:10946292, PubMed:11527969, PubMed:3458172, PubMed:6416294). Forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases (PubMed:10946292, PubMed:3458172, PubMed:6416294). May also regulate blood coagulation, fibrinolysis and the generation of kinins (PubMed:8495195). Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein (PubMed:8495195)
SERPING1 · P05155

Mean pLDDT
79.6/ 100
Confident
500 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0